Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Journal of Acquired Immune Deficiency Syndromes
Journal
Overview
Identity
Overview
Publication Venue For
The Impact of Cumulative Depression Along the HIV Care Continuum in Women Living With HIV During the Era of Universal Antiretroviral Treatment
. 82:225-233.
2019
Internalized HIV Stigma Is Associated With Concurrent Viremia and Poor Retention in a Cohort of US Patients in HIV Care
. 82:116-123.
2019
Brief Report: Aging Attenuates the Association Between Coronary Artery Calcification and Bone Loss Among HIV-Infected Persons
. 82:46-50.
2019
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART
. 81.
2019
Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV.
. 79:283-287.
2018
Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study
. 78:202-208.
2018
Experienced HIV-Related Stigma in Health Care and Community Settings: Mediated Associations With Psychosocial and Health Outcomes
. 77:257-263.
2018
Reply
. 77:e22.
2018
Reply.
. 77:e22.
2018
HIV Continuum of Care for Youth in the United States
. 77:110-117.
2018
Partner Notification for Youth Living With HIV in 14 Cities in the United States
. 77:46-52.
2018
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.
. 68:554-561.
2015
Biomarkers to monitor safety in people on art and risk of mortality.
. 60:51-58.
2012
Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.
. 61:390-399.
2012
A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet
. 56.
2011
Systemic and mucosal differences in hiv burden, immune, and therapeutic responses
. 56:401-411.
2011
Hepatitis B vaccination in HIV-infected youth: A randomized trial of three regimens
. 56:325-332.
2011
The effect of intermittent IL-2 therapy on CD4 T cells in the gut in HIV-1-infected patients
. 56:340-343.
2011
CD8 T-cell proliferative capacity is compromised in primary HIV-1 infection
. 56:213-221.
2011
Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: Still a missed opportunity for public health and HIV prevention
. 55.
2010
Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the roche COBAS ampliprep/COBAS TaqMan HIV-1 Version 1.0 viral load test
. 54:442-444.
2010
Epidemiology of HIV infection and risk in adolescents and youth
. 54.
2010
Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia
. 54:63-70.
2010
Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for zidovudine weight-based dosing
. 53:215-221.
2010
Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent haart Era
. 53:102-106.
2010
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression
. 52:357-363.
2009
Gender differences in discontinuation of antiretroviral treatment regimens
. 52:336-341.
2009
Predictors of rapid HIV testing acceptance and successful nevirapine administration in zambian labor wards
. 52:273-279.
2009
The major histocompatibility complex conserved extended haplotype 8.1 in aids-related non-hodgkin lymphoma
. 52:170-179.
2009
Effect of flash-heat treatment on immunoglobulins in breast milk
. 51:264-267.
2009
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir
. 50:290-293.
2009
Racial disparities in HIV virologic failure: Do missed visits matter?
. 50:100-108.
2009
Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: The fat redistribution and metabolic change in HIV infection (FRAM) study
. 48:142-148.
2008
Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women
. 48:203-210.
2008
Regional adipose tissue and elevations in serum aminotransferases in HIV-infected individuals
. 48:169-176.
2008
Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: A case series and systematic review
. 48:63-67.
2008
Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy
. 47:553-558.
2008
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: Results of ACTG A5186
. 47:459-466.
2008
The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy
. 47:194-201.
2008
Enrollment and retention of HIV discordant couples in Lusaka, Zambia
. 47:116-125.
2008
Inclusion of adolescents in preventive HIV vaccine trials: Public health policy and research design at a crossroads
. 47:86-92.
2008
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients
. 46:607-615.
2007
Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women
. 45:60-65.
2007
Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings
. 44:525-530.
2007
Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum.
. 43:378-380.
2006
Multiperson use of syringes among injection drug users in a needle exchange program: A gene-based molecular epidemiologic analysis
. 43:335-343.
2006
Bacterial disease in HIV-infected patients: The blind spot of highly active antiretroviral therapy? [3]
. 41:532-535.
2006
Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population
. 40:521-526.
2005
Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359
. 40:301-306.
2005
Modeling long-term HIV dynamics and antiretroviral response: Effects of drug potency, pharmacokinetics, adherence, and drug resistance
. 39:272-283.
2005
Immune activation and oxidative damage in HIV-positive and HIV-negative adolescents
. 38:180-190.
2005
Association of complementary and alternative medicines with HIV clinical disease among a cohort of women living with HIV/AIDS
. 37:1415-1422.
2004
Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals
. 37:1358-1366.
2004
Cytokine and Chemokine Gene Polymorphisms among Ethnically Diverse North Americans with HIV-1 Infection
. 35:446-454.
2004
Effects of Growth Hormone on Abnormal Visceral Adipose Tissue Accumulation and Dyslipidemia in HIV-Infected Patients
. 35:239-252.
2004
Detection of Nevirapine in Plasma Using Thin-Layer Chromatography
. 35:155-157.
2004
Tolerance and Safety of Different Concentrations of Chlorhexidine for Peripartum Vaginal and Infant Washes: HIVNET 025
. 35:138-143.
2004
A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program.
. 37 Suppl 2.
2004
Cross-reactive CD8
+
T cell epitopes identified in US adolescent minorities
. 33:426-438.
2003
Intermittent administration of high-dose stavudine to nucleoside-experienced individuals infected with HIV-1
. 33:343-348.
2003
The complexity of HLA class II (DRB1, DQB1, DM) associations with disseminated Mycobacterium avium complex infection among HIV-1-seropositive whites
. 33:140-145.
2003
Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection
. 33:56-65.
2003
Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings
. 32:506-513.
2003
Voluntary Counseling and Testing for HIV Among Pregnant Women Presenting in Labor in Kigali, Rwanda
. 31:408-415.
2002
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
. 31:257-275.
2002
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS vaccine evaluation group protocol 022A
. 29:254-261.
2002
Pharmacokinetic enhancement of protease inhibitors
. 29.
2002
Identity
International Standard Serial Number (issn)
1525-4135
Electronic International Standard Serial Number (eissn)
1944-7884